Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Edesa Biotech, Inc.

NASDAQ: EDSA · Life Sciences · 4 alerts · CIK 1540159

Share price
$1.89Close, Nov 16
Market cap
$18.2M
Shares outstanding
9.64MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Edesa Biotech, Inc. filings on SEC EDGAR ↗

9:25 AM ET 8-K
Regulatory Approval

Edesa Biotech Regulatory Approval

Edesa Biotech announced that the European Commission has granted orphan designation to its investigational drug paridiprubart for the treatment of Acute Respiratory Distress Syndrome (ARDS). The designation provides regulatory incentives including reduced development fees and potential market exclusivity for up to 10 years following approval.

Counterparty
European Commission
Term
10 years
6:05 AM ET 8-K
Licensing Deal

Edesa Biotech Licensing Deal with Kyorin Pharmaceutical Co., Ltd. Worth $146M

Edesa Biotech granted Kyorin Pharmaceutical an exclusive license to develop and commercialize its anti-TLR4 monoclonal antibody, paridiprubart (EB05), for the treatment of ARDS in Japan. Edesa receives a $12 million upfront payment and is eligible for up to $134 million in development, regulatory, and sales milestones, plus tiered double-digit royalties. Kyorin will fund all development and commercialization activities in Japan while Edesa retains rights in all other territories.

Value
$146M
Counterparty
Kyorin Pharmaceutical Co., Ltd.
Term
15 years
5:25 PM ET 8-K
Executive Compensation

Edesa Biotech Executive Compensation

Edesa Biotech approved significant annual base salary increases for its top executives, including CEO Dr. Pardeep Nijhawan, President Dr. Michael Brooks, and CFO Peter Weiler. The raises are retroactive to July 1, 2026, and represent the first adjustments to executive base salaries since 2023.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.